Paper20032327
Lp(a) lipoprotein redux--from curious molecule to causal risk factor.
Kathiresan S. N Engl J Med, 2009. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. Lp(a) lipoprotein redux--from curious molecule to causal risk factor. Papers, record 20032327. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20032327
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Coronary Disease | Major topic |
| Genetic Predisposition to Disease | Major topic |
| Lipoprotein(a) | Major topic |
| Polymorphism, Single Nucleotide | Major topic |
| Genetic Markers | |
| Genotype | |
| Humans | |
| Kringles | |
| Oligonucleotide Array Sequence Analysis | |
| Risk Factors |
Source PubMed
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 20335594 | Genetic variants in Lp(a) lipoprotein and coronary disease. | https://conductscience.org/library/papers/20335594 | PubMed |
| Comment on | 20032323 | Genetic variants associated with Lp(a) lipoprotein level and coronary disease. | https://conductscience.org/library/papers/20032323 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42416767 | Association of Lipoprotein(a) and ApoB/ApoA1 Ratio with SYNTAX Score in Premature Myocardial Infarction: an Age-Stratified Study from Northeast India. | Maedica (Bucur) | 2026 | https://conductscience.org/library/papers/42416767 | PubMed |
| 31185701 | The Potential Role of Genomic Medicine in the Therapeutic Management of Rheumatoid Arthritis. | J Clin Med | 2019 | https://conductscience.org/library/papers/31185701 | PubMed |
| 26839334 | Lipoprotein (a): Coming of Age at Last. | J Lipid Res | 2016 | https://conductscience.org/library/papers/26839334 | PubMed |
| 25736345 | Targeting lipoprotein (a): an evolving therapeutic landscape. | Curr Atheroscler Rep | 2015 | https://conductscience.org/library/papers/25736345 | PubMed |
| 24019032 | Dyslipidaemia: PCSK9 antibodies: a dividend of the genomics revolution. | Nat Rev Cardiol | 2013 | https://conductscience.org/library/papers/24019032 | PubMed |
| 21701618 | Safety and efficacy of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemia. | Drug Healthc Patient Saf | 2010 | https://conductscience.org/library/papers/21701618 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20032327
GET https://conductscience.org/api/papers/v1/20032327/authors